STAT3 and primary cutaneous T-cell non-Hodgkin lymphoma: Although we were not able to prove this mechanistic pathway in this study, our results imply that GD3 may regulate IL-17A production in benign CD4 T cells of CTCL by activating SHP-1 and suppressing the phosphorylation of STAT3 via siglec-7.